D-1030-2014 Class II Terminated

Recalled by KVK-Tech, Inc. — Newtown, PA

FDA drug recall D-1030-2014 was initiated by KVK-Tech, Inc. on Dec 11, 2013 and is designated Class II. Reason for recall: Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source. The recall status is terminated (terminated Aug 3, 2015). Affected quantity: 14664 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 29, 2014
Initiation Date
Dec 11, 2013
Termination Date
Aug 3, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14664 bottles

Product description

HydrOXYzine HCI Tablets USP 10 mg, 100 count bottles, Rx only. Mfd by KVK-TECH, INC, Newtown, PA 18940. NDC #10702-010-01.

Reason for recall

Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.

Distribution pattern

Nationwide, including Puerto Rico to wholesale distributors for sale to retail establishments.

Code information

lot #11434, exp. Nov-14

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1030-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1030-2014. Report a data issue: hello@regdatalab.com.